337 related articles for article (PubMed ID: 26320450)
21. Analysis of tumor marker CA 125 in saliva of normal and oral squamous cell carcinoma patients: a comparative study.
Balan JJ; Rao RS; Premalatha BR; Patil S
J Contemp Dent Pract; 2012 Sep; 13(5):671-5. PubMed ID: 23250173
[TBL] [Abstract][Full Text] [Related]
22. Identification of Salivary Biomarkers for Oral Cancer Detection with Untargeted and Targeted Quantitative Proteomics Approaches.
Chu HW; Chang KP; Hsu CW; Chang IY; Liu HP; Chen YT; Wu CC
Mol Cell Proteomics; 2019 Sep; 18(9):1796-1806. PubMed ID: 31253657
[TBL] [Abstract][Full Text] [Related]
23. Role of salivary biomarkers in early detection of oral squamous cell carcinoma.
Awasthi N
Indian J Pathol Microbiol; 2017; 60(4):464-468. PubMed ID: 29323056
[TBL] [Abstract][Full Text] [Related]
24. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma.
Rhodus NL; Ho V; Miller CS; Myers S; Ondrey F
Cancer Detect Prev; 2005; 29(1):42-5. PubMed ID: 15734216
[TBL] [Abstract][Full Text] [Related]
25. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-375 as a biomarker for malignant transformation in oral lesions.
Harrandah AM; Fitzpatrick SG; Smith MH; Wang D; Cohen DM; Chan EK
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Dec; 122(6):743-752.e1. PubMed ID: 27720656
[TBL] [Abstract][Full Text] [Related]
27. Detection of survivin, carcinoembryonic antigen and ErbB2 level in oral squamous cell carcinoma patients.
Li SX; Yang YQ; Jin LJ; Cai ZG; Sun Z
Cancer Biomark; 2016; 17(4):377-382. PubMed ID: 27662323
[TBL] [Abstract][Full Text] [Related]
28. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
29. Expression of CDK6 in Oral Squamous Cell Carcinomas.
Andisheh-Tadbir A; Ashraf MJ; Jeiroodi N
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1013-1016. PubMed ID: 29693970
[TBL] [Abstract][Full Text] [Related]
30. Chronic periodontitis can affect the levels of potential oral cancer salivary mRNA biomarkers.
Cheng YL; Jordan L; Chen HS; Kang D; Oxford L; Plemons J; Parks H; Rees T
J Periodontal Res; 2017 Jun; 52(3):428-437. PubMed ID: 27549383
[TBL] [Abstract][Full Text] [Related]
31. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
Sun L; Feng J; Ma L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
[TBL] [Abstract][Full Text] [Related]
32. Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma.
Malhotra R; Urs AB; Chakravarti A; Kumar S; Gupta VK; Mahajan B
Tumour Biol; 2016 Jul; 37(7):9263-71. PubMed ID: 26779624
[TBL] [Abstract][Full Text] [Related]
33. Saliva protein biomarkers to detect oral squamous cell carcinoma in a high-risk population in Taiwan.
Yu JS; Chen YT; Chiang WF; Hsiao YC; Chu LJ; See LC; Wu CS; Tu HT; Chen HW; Chen CC; Liao WC; Chang YT; Wu CC; Lin CY; Liu SY; Chiou ST; Chia SL; Chang KP; Chien CY; Chang SW; Chang CJ; Young JD; Pao CC; Chang YS; Hartwell LH
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11549-11554. PubMed ID: 27663741
[TBL] [Abstract][Full Text] [Related]
34. Expression of Human Epidermal Growth Factor Receptor (Her 2/neu) and Proliferative Marker Ki-67: Association with Clinicopathological Parameters in Gallbladder Carcinoma.
Pujani M; Makker I; Makker A; Jetley S; Goel MM; Jetley S
Asian Pac J Cancer Prev; 2016; 17(8):3903-9. PubMed ID: 27644637
[TBL] [Abstract][Full Text] [Related]
35. Expression of immunoregulatory molecules PD-L1 and PD-1 in oral cancer and precancerous lesions: A cohort study of Japanese patients.
Kouketsu A; Sato I; Oikawa M; Shimizu Y; Saito H; Takahashi T; Kumamoto H
J Craniomaxillofac Surg; 2019 Jan; 47(1):33-40. PubMed ID: 30466788
[TBL] [Abstract][Full Text] [Related]
36. Monitoring carcinogenesis in a case of oral squamous cell carcinoma using a panel of new metabolic blood biomarkers as liquid biopsies.
Grimm M; Hoefert S; Krimmel M; Biegner T; Feyen O; Teriete P; Reinert S
Oral Maxillofac Surg; 2016 Sep; 20(3):295-302. PubMed ID: 26875085
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Salivary and Serum Soluble CD44 Levels between Patients with Oral SCC and Healthy Controls.
Seyedmajidi S; Seyedmajidi M; Foroughi R; Zahedpasha A; Zolfaghari Saravi Z; Pourbagher R; Bijani A; Motallebnejad M; Monfared Shabestani A; Mostafazadeh A
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3059-3063. PubMed ID: 30485941
[TBL] [Abstract][Full Text] [Related]
38. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical Evaluation of GLUT-3 and GLUT-4 in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Feitosa SG; Viana KF; Luna ECM; Costa FWG; Cavalcante RB; Chaves FN; Chaves HV; Pereira KMA
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1779-1783. PubMed ID: 30049187
[TBL] [Abstract][Full Text] [Related]
40. Increased salivary AKR1B10 level: Association with progression and poor prognosis of oral squamous cell carcinoma.
Ko HH; Peng HH; Cheng SJ; Kuo MY
Head Neck; 2018 Dec; 40(12):2642-2647. PubMed ID: 30430672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]